| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317791 | Clinical Biochemistry | 2012 | 5 Pages |
Abstract
⺠Endothelial dysfunction contributes to the enhanced cardiovascular morbidity in RA. ⺠ADMA represents a novel biomarker of endothelial dysfunction. ⺠Despite clinical improvement, anti-TNFα treatment does not affect ADMA in RA.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Aamer Sandoo, Theodoros Dimitroulas, Tracey E. Toms, James Hodson, Jet J.C.S. Veldhuijzen van Zanten, Jacqueline P. Smith, George D. Kitas,